These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32088019)

  • 1. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands.
    Vos RA; Pasmans H; Tymchenko L; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; de Melker HE; van der Klis FRM
    Vaccine; 2020 Mar; 38(13):2816-2826. PubMed ID: 32088019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.
    Scherpenisse M; Mollers M; Schepp RM; Boot HJ; Meijer CJ; Berbers GA; van der Klis FR; de Melker HE
    PLoS One; 2012; 7(11):e48807. PubMed ID: 23152809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High varicella zoster virus susceptibility in Caribbean island populations: Implications for vaccination.
    Vos RA; Mollema L; van Boven M; van Lier A; Smits G; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; Stienstra Y; van der Klis FRM; de Melker HE
    Int J Infect Dis; 2020 May; 94():16-24. PubMed ID: 32112964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of seven high-risk HPV types in The Netherlands.
    Scherpenisse M; Mollers M; Schepp RM; Boot HJ; de Melker HE; Meijer CJ; Berbers GA; van der Klis FR
    Vaccine; 2012 Oct; 30(47):6686-93. PubMed ID: 22959981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands.
    Vos RA; Mollema L; van Binnendijk R; Veldhuijzen IK; Smits G; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; van der Klis FRM; Melker HE
    Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31581508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in HPV Seroprevalence from an Unvaccinated toward a Girls-Only Vaccinated Population in the Netherlands.
    Pasmans H; Hoes J; Tymchenko L; de Melker HE; van der Klis FRM
    Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2243-2254. PubMed ID: 32856612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.
    Ortiz AP; Tortolero-Luna G; Romaguera J; Pérez CM; González D; Muñoz C; González L; Marrero E; Suárez E; Palefsky JM; Panicker G; Unger ER
    Papillomavirus Res; 2018 Jun; 5():109-113. PubMed ID: 29555601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study.
    Zhang C; Liu F; Deng Q; He Z; Xi L; Liu Y; Pan Y; Ning T; Guo C; Xu R; Zhang L; Cai H; Ke Y
    Sex Transm Infect; 2015 Nov; 91(7):506-9. PubMed ID: 25999521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program.
    Učakar V; Jelen MM; Faust H; Poljak M; Dillner J; Klavs I
    Vaccine; 2013 Oct; 31(43):4935-9. PubMed ID: 23994822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional seroprevalence of antibodies against 6, 11, 16 and 18 human papilloma virus (HPV) types among teenagers and young women in Italy.
    Lupi S; Bergamini M; Guidi E; Gregorio P;
    Ann Ist Super Sanita; 2014; 50(2):171-7. PubMed ID: 24968917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage.
    Gray P; Kann H; Pimenoff VN; Adhikari I; Eriksson T; Surcel HM; Vänskä S; Dillner J; Faust H; Lehtinen M
    Int J Cancer; 2020 Dec; 147(12):3511-3522. PubMed ID: 32574384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
    Chen CJ; Viscidi RP; Chuang CH; Huang YC; Chiu CH; Lin TY
    J Clin Virol; 2007 Feb; 38(2):126-30. PubMed ID: 17210269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
    Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
    Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women.
    Ng K; Morais S; Wissing MD; Burchell AN; Tellier P-P; Coutlée F; Waterboer T; El-Zein M; Franco EL
    Microbiol Spectr; 2024 Jun; 12(6):e0022924. PubMed ID: 38687066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin and mucosal human papillomavirus seroprevalence in persons with Fanconi Anemia.
    Katzenellenbogen RA; Carter JJ; Stern JE; Butsch Kovacic MS; Mehta PA; Sauter SL; Galloway DA; Winer RL
    Clin Vaccine Immunol; 2015 Apr; 22(4):413-20. PubMed ID: 25651924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological study.
    Immink MM; Vos ERA; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; van Vliet J; Kerkhof J; den Hartog G; de Melker HE; van der Klis FRM; van der Maas NAT
    Int J Infect Dis; 2021 Oct; 111():21-27. PubMed ID: 34407478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling the seroprevalence of human papillomavirus in Guangdong, China: Implications for vaccination strategies.
    Hu X; Chen Y; Lin W; Ruan Q; Chen H; Li X; Deng Y; Liang C; Lin H; Zeng L; Sun N; Zhao W; Chen L; Yang Y; Sun L; He J; Sun J
    J Med Virol; 2024 Sep; 96(9):e29910. PubMed ID: 39228341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.
    Ermel AC; Shew ML; Weaver BA; Qadadri B; Denski C; Tu W; Tong Y; Fortenberry JD; Brown DR
    Sex Transm Infect; 2014 Feb; 90(1):64-9. PubMed ID: 24031030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.
    Mehta PA; Sauter S; Zhang X; Davies SM; Wells SI; Myers KC; Panicker G; Unger ER; Butsch Kovacic M
    Vaccine; 2017 Dec; 35(48 Pt B):6712-6719. PubMed ID: 29042204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.